yeah I also thought that, perhaps it is in the numbers of their modelling somewhere but it didn't jump out at me... I.e. what would their valuation be if the trial is a success?
they mention expecting a capital raise next year but without a view on the price they expect (assuming good results in trial) then I don't see how a capital raise can be taken into account...
- Forums
- ASX - By Stock
- DLM
- Ann: CEO presentation to Broker Meets Biotech - Perth
Ann: CEO presentation to Broker Meets Biotech - Perth, page-62
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DLM (ASX) to my watchlist
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable